Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study-Reference-Cited by-同舟云学术

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Published:2021-08 Issue:8 Volume:20 Page:615-626
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Fagan Anne M,Henson Rachel L,Li Yan,Boerwinkle Anna H,Xiong Chengjie,Bateman Randall J,Goate Alison,Ances Beau M,Doran Eric,Christian Bradley T,Lai Florence,Rosas H Diana,Schupf Nicole,Krinsky-McHale Sharon,Silverman Wayne,Lee Joseph H,Klunk William E,Handen Benjamin L,Allegri Ricardo F,Chhatwal Jasmeer P,Day Gregory S,Graff-Radford Neill R,Jucker Mathias,Levin Johannes,Martins Ralph N,Masters Colin L,Mori Hiroshi,Mummery Catherine J,Niimi Yoshiki,Ringman John M,Salloway Stephen,Schofield Peter R,Shoji Mikio,Lott Ira T

Funder

NIH

Japan Agency for Medical Research and Development

Eunice Kennedy Shriver National Institute of Child Health and Human Development

German Centre for Neurodegenerative Diseases

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference39 articles.

1. Alzheimer's disease and Down's syndrome;Mann;Histopathology,1988

2. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study;Fortea;Lancet,2020